Consultant of Diagnostic & Genomic Medicine Unit (DGMU)
Genomic Screening & Neurogenomics Research Groups
Extraordinary experience in Initiating and maintaining Intra-institutional links. Supervise national and international MSc as well as PhD students registered with KAU. Initiate and monitor various development programs at FAMS, KAU. Establish and manage various committees at KFMRC and CEGMR including publication, post graduate & ethical committees. Founder & president of Saudi oncology research society SSGMO. Implement and manage various accreditation programs at FAMS such as IBMS, NCAAA and AHPGS. Manage distinguished professors’ program at CEGMR and FAMS. Initiate & support international technical\ scientific workshops for Saudi post graduates in Oncology research. Member of research committee in health sciences @ KACST. Coordinate PR at CIPM, KAU. Principle investigator and co-investigator on several projects including Autism, Congenital Heart Disease, Intellectual disability and Breast Cancer susceptibility genes' chip development project. Subject coordination for molecular biology and biotechnology at the FAMS MSc program. Head of neurogenetics research group
at CEGMR with interest in duchenne muscular dystrophy, spinal muscular atrophy juvenile myoclonic epilepsy, autism, fragile & intellectual disabilities.
Abb: CEGMR; Center of Excellence for Genomic Medicine Research. FAMS; Faculty of Applied Medical Sc. KAU; King Abdulaziz University. KACST; King Abdulaziz City for Science & Technology. SSGMO; Saudi Society for Genomic & Molecular Oncology Research. HiCi; Thomas Reuters Highly Cited. KFMRC; King Fahd Medical Research Center. CIPM; Center for Innovation in Personalized Medicine
Appointed as demonstrator in 1993 at the Faculty of Applied Medical Sciences. King Abdulaziz University (KAU), Jeddah, Saudi Arabia. In 2010 I was promoted to associate professor. Current academic activities include coordinating Molecular Genetics and Biotechnology modules at undergraduate & post graduate level.
Vice-director for technical affairs at the Center of Excellence in Genomic Medicine Research at KAU. Under the Umbrella of Ministry of Higher Education, the center established in 2008 currently excels in providing fundamental research platforms in Cancer genetics, neurogenetics, genomic screening and Adult stem cell biology. Established joint MSc & PhD programs. Hosts international conferences, 'hands-on' workshops in DNA sequencing, PCRs, real-time analysis, microarray and cytogenetics.
Consultant at DGMU since inception in 2003...now a CAP accredited lab that provides state-of- the art diagnostic solutions for a range of disease markers in Cytogenetics, Molecular Cytogenetics and Molecular Genetics.
Diagnostic Radiology and radiotherapy undergraduate program at Faculty of Applied Medical Sciences, KAU, Jeddah. A five year undergraduate program that allows students to obtain in-depth theoretical as well as technical knowledge in MRI, CT, Ultrasound, Ultrasonography, Echocardiography and General X-ray
Vice-dean for development
Faculty of Applied Health Sciences,
King Abdulaziz University
Head of Research & Scientific Affairs
King Fahd Medical Research Center
February 2012 – 2014,
King Abdulaziz University
Associate Prof, Vice Director Center of Excellence in Genomic Medicine Research
Center of Excellence in Genomic Medicine Research, King Abdulaziz University
September 1993 – Present
1. Evaluation of Her-2/neu gene amplification in Saudi female breast cancer patients using quantitative real-time PCR and fluorescence in situ hybridization.
Chaudhary AG, Al-Juhani MA, Azam J, Al-Maghrabi J, Gari M, Abuzenadah A, Al-Qahtani M.
2. Establishing an array CGH platform for molecular diagnosis of Saudi patients with intellectual disability
Journal of Molecular Genetics. 2011; 3 (2): 12-22.
3. Molecular Basis of Beta-Thalassemia in the Western province of Saudi Arabia: Identification of rare β-thalassemia mutations
Abuzenadah A, Hussein IR, Damanhoury G, El Sayes F, Zaher G, Gari M, Chaudhary AG, Al-Attas A, Al-Qahtani M
4. RASSF1A methylation is predictive of poor prognosis in breast cancer in the background of overall low methylation Frequency
Buhmeida A, Al-Maghrabi J, Merdad A, Al-Thubaity F, Hidmi M, Boghas A, Syrjanen K, Chaudhary A, Gari M, Abuzenadah A, Al-Qahtani M, Dallol A
Anticancer Res. 2011 Sep;31(9):2975-81.
5. Prognostic value of mitotic counts in breast cancer of Saudi Arabian patients
Buhmeida A, Al-Maghrabi J, Merdad A, Al-Thubaity F, Chaudhary A, Gari M, Abuzenadah A, Collan Y, Syrj?nen K, Al-Qahtani M.
Anticancer Res. 2011 Jan;31(1):97-103.